HHS SECRETARY-DESIGNATE SHALALA'S CONFIRMATION HEARING SLATED FOR JAN. 14
This article was originally published in The Gray Sheet
Executive Summary
HHS SECRETARY-DESIGNATE SHALALA'S CONFIRMATION HEARING SLATED FOR JAN. 14 before the Senate Finance Committee. The Finance Committee must subsequently vote on whether to recommend that the full Senate confirm Shalala's nomination. President-elect Clinton nominated the University of Wisconsin-Madison chancellor for the HHS position on Dec. 11 ("The Gray Sheet" Dec. 14, p. 11). Shalala may undergo thorough questioning by the committee, but her nomination is expected to sail smoothly through the Democratic Senate. Though some conservatives have voiced concern about Shalala's reputation as a strong liberal, as exemplified by an effort to establish a code against "hate speech" on the Wisconsin campus, such objections may be quieted if, as expected, Wisconsin officials introducing Shalala at the hearing include either Republican Gov. Tommy Thompson or Rep. Scott Klug. Shalala traveled to Capitol Hill on Jan. 8 in keeping with the tradition of administration nominees paying courtesy visits to members of Congress. Finance Ranking Republican Bob Packwood (Ore.) was among the senators who met with her. The Finance Committee hearing is expected to be chaired by incoming Chairman Patrick Moynihan (D-N.Y.), part of the transferring of responsibilities from current committee chairman and Treasury Secretary-designate Lloyd Bentsen (D-Tex.). Bentsen's own confirmation hearing before the Finance Committee is scheduled for Jan. 12. Bentsen and Moynihan have not announced yet whether they will give their current staffers new positions when the chairmanship changes hands. Moynihan's legislative aide for health policy, Faye Drummond, has worked for the senator since 1978. She holds an MPH from Johns Hopkins and an MA in childhood education. Another aide on social issues, Paul Offner, was involved in one of Moynihan's major legislative proposals last year, a Medicaid managed care bill. Moynihan's chief counsel, Joseph Gale, oversees tax issues. Moynihan generally has been supportive of Sec. 936 tax credits.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.